Marinomed Biotech AG Announces Capital Increase Excluding Subscription Rights

Marinomed Biotech AG has resolved to increase its share capital. The increase involves issuing 154,053 new no-par value bearer shares at EUR 5 each. This action raises the company's share capital by EUR 154,053 to EUR 1,694,583. The total issue price for the new shares amounts to EUR 770,265. Existing shareholders' statutory subscription rights are excluded.

The company's Supervisory Board approved this capital increase. Eleven investors, including board members, have subscribed to these new shares.

Negotiations for a potential second capital increase are ongoing. This could involve another 154,053 shares. However, its execution depends on various factors, including investor negotiations and approvals from the Management Board and Supervisory Board.